VWF and hemophilia A: In particular, hemophilia A patients carrying a Tyr1680Phe, Ser2119Tyr, Arg2150His replacement or deletion of Ala2201, respond to DDAVP treatment by a concomitant increase of FVIII and VWF [22], [29].